Medical treatments for hepatocellular carcinoma (HCC): what's next?

被引：27

作者：

Taieb, J. ^{[1
]}

Barbare, J. C.

Rougier, P.

机构：

[1] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75634 Paris, France

[2] Ctr Hosp, Serv Hepatogastroenterol, Compiegne, France

[3] Hop Ambroise Pare, Serv Hepatogastroenterol, Boulogne, France

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

10.1093/annonc/mdl279

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：X308 / X314

页数：7

共 80 条

[71] Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial [J].

Takayama, T ;

Sekine, T ;

Makuuchi, M ;

Yamasaki, S ;

Kosuge, T ;

Yamamoto, J ;

Shimada, K ;

Sakamoto, M ;

Hirohashi, S ;

Ohashi, Y ;

Kakizoe, T .

LANCET, 2000, 356 (9232) :802-807

[72] Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma [J].

Torimura, T ;

Sata, M ;

Ueno, T ;

Kin, M ;

Tsuji, R ;

Suzaku, K ;

Hashimoto, O ;

Sugawara, H ;

Tanikawa, K .

HUMAN PATHOLOGY, 1998, 29 (09) :986-991

[73] Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus [J].

Valla, DC ;

Degos, F .

JOURNAL OF HEPATOLOGY, 2001, 34 (04) :606-609

[74] 5-FLUOROURACIL AND LEUCOVORIN IN HEPATOCELLULAR-CARCINOMA [J].

VANEEDEN, H ;

FALKSON, G ;

BURGER, W ;

ANSELL, SM .

ANNALS OF ONCOLOGY, 1992, 3 (05) :404-405

[75] Phase II trial to topotecan in hepatocellular carcinoma: A Southwest Oncology Group study [J].

Wall, JG ;

Benedetti, JK ;

ORourke, MA ;

Natale, RB ;

Macdonald, JS .

INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) :257-260

[76]

Yamamoto J, 1996, BRIT J SURG, V83, P1219

[77] A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma [J].

Yeo, W ;

Mok, TS ;

Zee, B ;

Leung, TWT ;

Lai, PBS ;

Lau, WY ;

Koh, J ;

Mo, FKF ;

Yu, SCH ;

T Chan, A ;

Hui, P ;

Ma, B ;

Lam, KC ;

Ho, WM ;

Wong, HT ;

Tang, A ;

Johnson, PJ .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20) :1532-1538

[78] A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma [J].

Yuen, MF ;

Poon, RTP ;

Lai, CL ;

Fan, ST ;

Lo, CM ;

Wong, KW ;

Wong, WM ;

Wong, BCY .

HEPATOLOGY, 2002, 36 (03) :687-691

[79]

ZHU AX, 2005, P AN M AM SOC CLIN, V23, P4120

[80]

ZHU AX, 2006, P AM SOC CLIN ONC GA, pA197

← 1 2 3 4 5 6 7 8 →